Find your way with ClarityNav.

Lori leads the Medical and Scientific Affairs Practice at Putnam. Her expertise includes multi-stakeholder engagement, center of excellence profiling, organizational design, strategic medical launches, integrated medical evidence ideation, omnichannel strategy, and digital health platforms, including digital therapeutics, AI algorithms, and software as a medical device. Lori has experience in rare diseases including Duchenne muscular dystrophy, hemophilia, growth hormone deficiency, cardiac amyloidosis, acromegaly, sickle cell disease, and primary hyperoxaluria as well as oncology, infectious disease, cardiology, critical care, neurology, and endocrinology. Prior to Putnam, Lori had a Medical Affairs strategy consultancy, built the Medical Affairs division at CDM and later became President. Earlier in her career she gained experience in medical education and MSL training at Bayer, and clinical research at the University of Minnesota. Lori holds an RPh from the University of Iowa, a PharmD from the University of Minnesota, and completed a postdoctoral fellowship in critical care and infectious diseases at the University of Minnesota.

Matt serves clients within the life science industry on commercial strategy issues. He has led projects that leverage detailed and integrative analytics to inform critical strategic decisions, focused on market opportunity identification (including physician and patient segmentation), product positioning and launch strategies, and customer engagement model design. He has deep expertise in complex hematology/ oncology, immunology, and orphan disease markets, with significant experience in cardiovascular, CNS, and infectious disease markets. He has led multiple internal knowledge development initiatives for the firm, including research on state-of-the art approaches to segmentation, understanding adherence from a business perspective, and integrating clinical and access research to inform comprehensive assessments of market potential. Matt is a guest lecturer at Harvard, MIT, and the Broad Institute. He earned his MBA from the Yale School of Management in Yale’s Healthcare MBA program and his BA in Economics from Boston College.